Janssen Korea said Thursday that its schizophrenia medication Invega Sustenna will be covered by national health insurance from Oct. 1.
It means insured patients can buy one month dose of the drug at reduced prices which vary from 12,000 won ($10) to 34,000 won depending on the severity of symptoms.
According to the drug maker, the medicine is proven to ease symptoms of schizophrenia significantly and can be used to lessen the recurrence of schizophrenia symptoms after a long latency.
(
baejisook@heraldcorp.com)
